News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Weill Cornell Medicine Faculty Inducted into Association of American Physicians

awards

Three distinguished Weill Cornell Medicine physician-scientists, Dr. Matthew Greenblatt, Dr. Lishomwa Ndhlovu and Dr. Sallie Permar, have been elected to the prestigious Association of American Physicians (AAP).

Regarded as one of the top honors in the field of health and medicine, election to the AAP recognizes physician-scientists who exhibit excellence in the pursuit of medical knowledge and the advancement of basic or translational science through experimentation and discovery and its application to clinical medicine.

Dr. Matthew Greenblatt, the Rohr Family Research Scholar and an associate professor of pathology and laboratory medicine at Weill Cornell Medicine, was recognized for his pioneering work discovering new stem cells that govern vertebral physiology and breast and prostate cancer metastasis. 

Dr. Greenblatt

Dr. Matthew Greenblatt

A VAST New View of Viruses

blue and red drawing of different types of viruses

A major new effort at Weill Cornell Medicine seeks to catalog the normal human virome, the immense ecosystem of viruses that lives in and on us. The work, part of a multi-institution collaboration called Viromes Across Space and Time (VAST), supported by the National Institute on Aging, part of the National Institutes of Health, will pioneer new techniques, illuminate a crucial aspect of human biology that was impossible to study before, and establish a baseline set of data that could help in preventing, diagnosing and treating disease.

Most viruses don’t make humans sick. Indeed, virologists have long suspected that the world is awash in viruses that cause no disease and that traditional lab tests can’t detect, but recent advances in DNA and RNA sequencing and bioinformatics have finally allowed them to probe this biological dark matter. Understandably, much of that work has focused on how changes in the virome can contribute to disease. The new project tackles an equally important question: what does a healthy virome look like?

Diagnose to Cure: Developing RNA-based TB Testing

six people standing in front of a building with a sign reading "Tuberculosis and Clinical Trial Unit (CTU) Laboratory"

In 2023, tuberculosis (TB) killed about 1.25 million people worldwide, more than any other infectious disease on Earth — even though it is curable. Months- or even years-long regimens of potent antibiotics can eradicate the Mycobacterium tuberculosis bacteria. And in about 88% of cases globally, treatment is successful in curing the disease. But for the remainder of patients, at least those for whom data is available, the disease re-emerges.

Dr. Kayvan Zainabadi